# Global Net Lease, Inc.: financial statements, quarterly

GNL · NYSE · CIK 1526113 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/gnl.md) · [Financials](/companies/gnl/financials.md) · [Filings](/companies/gnl/filings.md) · [Insiders](/companies/gnl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/gnl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [118](/filings/0001526113-24-000027.md) | [137 d](/filings/0001628280-26-011696.md) | [148](/filings/0001526113-25-000014.md) | [145](/filings/0001526113-25-000022.md) | [139](/filings/0001628280-25-050197.md) | [138 d](/filings/0001628280-26-011696.md) | [132](/filings/0001628280-26-031288.md) | [125](/filings/0001628280-26-053396.md) | [121](/filings/0001628280-25-050197.md) | [117 d](/filings/0001628280-26-011696.md) | [109](/filings/0001628280-26-031288.md) | [112](/filings/0001628280-26-053396.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [(95.6)](/filings/0001526113-24-000027.md) | [45.4 d](/filings/0001628280-26-011696.md) | [57.1](/filings/0001526113-25-000014.md) | [61.9](/filings/0001526113-25-000022.md) | [12.8](/filings/0001628280-25-050197.md) | [56.3 d](/filings/0001628280-26-011696.md) | [(27.9)](/filings/0001628280-26-031288.md) | [42.3](/filings/0001628280-26-053396.md) | [(14.2)](/filings/0001628280-25-050197.md) | [111 d](/filings/0001628280-26-011696.md) | [30.9](/filings/0001628280-26-031288.md) | [54.7](/filings/0001628280-26-053396.md) |
| Interest expense | $m | [41.2](/filings/0001526113-23-000026.md) | [83.6 d](/filings/0001526113-24-000007.md) | [82.8](/filings/0001526113-24-000014.md) | [72.0](/filings/0001526113-25-000022.md) | [59.5](/filings/0001628280-25-050197.md) | [59.6 d](/filings/0001628280-26-011696.md) | [53.4](/filings/0001628280-26-031288.md) | [53.3](/filings/0001628280-26-053396.md) | [45.3](/filings/0001628280-25-050197.md) | [42.6 d](/filings/0001628280-26-011696.md) | [39.2](/filings/0001628280-26-031288.md) | [38.8](/filings/0001628280-26-053396.md) |
| Income tax | $m | [2.8](/filings/0001526113-24-000027.md) | [5.5 d](/filings/0001628280-26-011696.md) | [2.4](/filings/0001526113-25-000014.md) | [(0.3)](/filings/0001526113-25-000022.md) | [1.3](/filings/0001628280-25-050197.md) | [1.0 d](/filings/0001628280-26-011696.md) | [3.3](/filings/0001628280-26-031288.md) | [3.0](/filings/0001628280-26-053396.md) | [3.1](/filings/0001628280-25-050197.md) | [12.4 d](/filings/0001628280-26-011696.md) | [1.6](/filings/0001628280-26-031288.md) | [4.8](/filings/0001628280-26-053396.md) |
| Net income | $m | [(136)](/filings/0001526113-24-000027.md) | [(48.6) d](/filings/0001628280-26-011696.md) | [(23.8)](/filings/0001526113-25-000014.md) | [(35.7)](/filings/0001526113-25-000022.md) | [(65.6)](/filings/0001628280-25-050197.md) | [(6.5) d](/filings/0001628280-26-011696.md) | [(189)](/filings/0001628280-26-031288.md) | [(24.1)](/filings/0001628280-26-053396.md) | [(60.1)](/filings/0001628280-25-050197.md) | [48.2 d](/filings/0001628280-26-011696.md) | [(5.1)](/filings/0001628280-26-031288.md) | [3.5](/filings/0001628280-26-053396.md) |
| Diluted EPS | $ per share | [(1.11)](/filings/0001526113-24-000027.md) | not reported | [(0.15)](/filings/0001526113-25-000014.md) | [(0.20)](/filings/0001526113-25-000022.md) | [(0.33)](/filings/0001628280-25-050197.md) | not reported | [(0.87)](/filings/0001628280-26-031288.md) | [(0.16)](/filings/0001628280-26-053396.md) | [(0.32)](/filings/0001628280-25-050197.md) | not reported | [(0.08)](/filings/0001628280-26-031288.md) | [(0.04)](/filings/0001628280-26-053396.md) |
| Basic EPS | $ per share | [(1.11)](/filings/0001526113-24-000027.md) | not reported | [(0.15)](/filings/0001526113-25-000014.md) | [(0.20)](/filings/0001526113-25-000022.md) | [(0.33)](/filings/0001628280-25-050197.md) | not reported | [(0.87)](/filings/0001628280-26-031288.md) | [(0.16)](/filings/0001628280-26-053396.md) | [(0.32)](/filings/0001628280-25-050197.md) | not reported | [(0.08)](/filings/0001628280-26-031288.md) | [(0.04)](/filings/0001628280-26-053396.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [133](/filings/0001526113-24-000027.md) | [122](/filings/0001628280-26-011696.md) | [132](/filings/0001526113-25-000014.md) | [122](/filings/0001526113-25-000022.md) | [127](/filings/0001628280-25-050197.md) | [160](/filings/0001628280-26-011696.md) | [147](/filings/0001628280-26-031288.md) | [145](/filings/0001628280-26-053396.md) | [165](/filings/0001628280-25-050197.md) | [180](/filings/0001628280-26-053396.md) | [125](/filings/0001628280-26-031288.md) | [154](/filings/0001628280-26-053396.md) |
| Total assets | $m | [8,185](/filings/0001526113-23-000026.md) | [8,099](/filings/0001526113-25-000007.md) | [7,969](/filings/0001526113-24-000014.md) | [7,613](/filings/0001526113-24-000021.md) | [7,336](/filings/0001526113-24-000027.md) | [6,956](/filings/0001628280-26-011696.md) | [5,789](/filings/0001526113-25-000014.md) | [4,985](/filings/0001526113-25-000022.md) | [4,765](/filings/0001628280-25-050197.md) | [4,347](/filings/0001628280-26-053396.md) | [4,152](/filings/0001628280-26-031288.md) | [4,066](/filings/0001628280-26-053396.md) |
| Total liabilities | $m | [5,391](/filings/0001526113-23-000026.md) | [5,460](/filings/0001526113-25-000007.md) | [5,442](/filings/0001526113-24-000014.md) | [5,189](/filings/0001526113-24-000021.md) | [5,061](/filings/0001526113-24-000027.md) | [4,769](/filings/0001628280-26-011696.md) | [3,874](/filings/0001526113-25-000014.md) | [3,153](/filings/0001526113-25-000022.md) | [3,064](/filings/0001628280-25-050197.md) | [2,684](/filings/0001628280-26-053396.md) | [2,591](/filings/0001628280-26-031288.md) | [2,557](/filings/0001628280-26-053396.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [2,792](/filings/0001526113-23-000026.md) | [2,638](/filings/0001526113-25-000007.md) | [2,525](/filings/0001526113-24-000014.md) | [2,421](/filings/0001526113-24-000021.md) | [2,273](/filings/0001526113-24-000027.md) | [2,187](/filings/0001628280-26-011696.md) | [1,916](/filings/0001526113-25-000014.md) | [1,832](/filings/0001526113-25-000022.md) | [1,701](/filings/0001628280-25-050197.md) | [1,663](/filings/0001628280-26-053396.md) | [1,561](/filings/0001628280-26-031288.md) | [1,509](/filings/0001628280-26-053396.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [3.6 d](/filings/0001526113-24-000027.md) | [55.8 d](/filings/0001628280-26-011696.md) | [92.2](/filings/0001526113-25-000014.md) | [70.4 d](/filings/0001526113-25-000022.md) | [62.1 d](/filings/0001628280-25-050197.md) | [74.8 d](/filings/0001628280-26-011696.md) | [59.2](/filings/0001628280-26-031288.md) | [52.0 d](/filings/0001628280-26-053396.md) | [56.0 d](/filings/0001628280-25-050197.md) | [55.6 d](/filings/0001628280-26-011696.md) | [39.7](/filings/0001628280-26-031288.md) | [67.1 d](/filings/0001628280-26-053396.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [42.0 d](/filings/0001526113-24-000027.md) | [81.7 d](/filings/0001628280-26-011696.md) | [81.7](/filings/0001526113-25-000014.md) | [63.5 d](/filings/0001526113-25-000022.md) | [63.5 d](/filings/0001628280-25-050197.md) | [63.8 d](/filings/0001628280-26-011696.md) | [63.9](/filings/0001628280-26-031288.md) | [43.5 d](/filings/0001628280-26-053396.md) | [42.3 d](/filings/0001628280-25-050197.md) | [42.3 d](/filings/0001628280-26-011696.md) | [41.3](/filings/0001628280-26-031288.md) | [40.6 d](/filings/0001628280-26-053396.md) |
| Share repurchases | $m | [0.8 d](/filings/0001526113-24-000027.md) | [(1.1) d](/filings/0001628280-26-011696.md) | [0.0](/filings/0001526113-25-000014.md) | [0.0 d](/filings/0001526113-25-000022.md) | [0.0 d](/filings/0001628280-25-050197.md) | [0.0 d](/filings/0001628280-26-011696.md) | [19.4](/filings/0001628280-26-031288.md) | [56.6 d](/filings/0001628280-26-053396.md) | [6.9 d](/filings/0001628280-25-050197.md) | [37.4 d](/filings/0001628280-26-011696.md) | [38.4](/filings/0001628280-26-031288.md) | [11.1 d](/filings/0001628280-26-053396.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [104](/filings/0001526113-23-000026.md) | [104](/filings/0001526113-24-000014.md) | [104](/filings/0001526113-24-000021.md) | [131](/filings/0001526113-24-000027.md) | [230](/filings/0001526113-25-000014.md) | [230](/filings/0001526113-25-000022.md) | [230](/filings/0001628280-25-050197.md) | [230](/filings/0001628280-26-031288.md) | [223](/filings/0001628280-26-053396.md) | [221](/filings/0001628280-25-050197.md) | [214](/filings/0001628280-26-031288.md) | [211](/filings/0001628280-26-053396.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 210,930,100 at 2026-08-03, from the cover of the [10-Q filed 2026-08-05](/filings/0001628280-26-053396.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:42 ET. No prices; not investment advice.